Stock Events

Stock Events

TELA Bio 

$1
0
+$0.01+1.02% Friday 06:03

Statistics

Day High
1
Day Low
0.99
52W High
-
52W Low
-
Volume
6
Avg. Volume
-
Mkt Cap
40.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MarExpected
Q3 2025
Next
-0.19
-0.19
-0.18
-0.18
Expected EPS
-0.178
Actual EPS
N/A

Financials

-54.6%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
138.6MRevenue
-75.68MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TELA.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the medical devices segment, offering products that could compete with TELA Bio's soft tissue reinforcement solutions.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers a wide range of medical devices that can compete with TELA Bio's offerings, especially in the surgical and wound care markets.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation provides medical solutions that could directly compete with TELA Bio's hernia repair and reconstructive surgery products.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation's medical and surgical equipment, including surgical meshes, can compete with TELA Bio's portfolio.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. offers advanced surgical products, including biologics and biosurgery products, that compete with TELA Bio's solutions.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories, with its range of medical devices and health care products, competes in the same space as TELA Bio, particularly in surgical care.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, known for its robotic-assisted surgical systems, competes indirectly by offering advanced surgical options that could reduce the need for traditional surgical meshes.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be used in procedures similar to those targeted by TELA Bio.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, a provider of regenerative technologies, directly competes with TELA Bio in the market for surgical reconstruction and repair products.

About

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Show more...
CEO
Mr. Antony Koblish
Employees
209
Country
US
ISIN
US8723811084

Listings

XNAS
US
TELA
BOATS
BOATS
TELA.BOATS

0 Comments

Share your thoughts

FAQ

What is TELA Bio stock price today?▼
The current price of TELA.BOATS is $1 USD — it has increased by +1.02% in the past 24 hours. Watch TELA Bio stock price performance more closely on the chart.
What is TELA Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange TELA Bio stocks are traded under the ticker TELA.BOATS.
What is TELA Bio market cap?▼
Today TELA Bio has the market capitalization of 40.34M
When is the next TELA Bio earnings date?▼
TELA Bio is going to release the next earnings report on March 19, 2026.
What were TELA Bio earnings last quarter?▼
TELA.BOATS earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.19 USD resulting in a +1.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is TELA Bio revenue for the last year?▼
TELA Bio revenue for the last year amounts to 138.6M USD.
What is TELA Bio net income for the last year?▼
TELA.BOATS net income for the last year is -75.68M USD.
How many employees does TELA Bio have?▼
As of February 02, 2026, the company has 209 employees.
In which sector is TELA Bio located?▼
TELA Bio operates in the Health Care sector.
When did TELA Bio complete a stock split?▼
TELA Bio has not had any recent stock splits.
Where is TELA Bio headquartered?▼
TELA Bio is headquartered in Malvern, US.